Sign in
4

Changes in Ownership

Eledon Pharmaceuticals, Inc. Filed Acc 0000899243-21-049171

Chief Executive Officer bought 2,000 shares at $4.48 ($8,960)

From the SEC's structured data for this filing

Trades in this filing

Gros David-Alexandre C · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-12-20 Purchase : show line 1 in the form +2,000 $4.48 $8,960 9,000 D
Open-market purchases · 2,000 sh · avg $4.48 · $8,960
Loading xslF345X03/doc4.xml…